Advertisement

Archives of Toxicology

, Volume 84, Issue 11, pp 891–896 | Cite as

Identification and distribution of mercury species in rat tissues following administration of thimerosal or methylmercury

  • Jairo L. Rodrigues
  • Juliana M. Serpeloni
  • Bruno L. Batista
  • Samuel S. Souza
  • Fernando BarbosaJr
Inorganic Compounds

Abstract

Methylmercury (Met-Hg) is one the most toxic forms of Hg, with a considerable range of harmful effects on humans. Sodium ethyl mercury thiosalicylate, thimerosal (TM) is an ethylmercury (Et-Hg)-containing preservative that has been used in manufacturing vaccines in many countries. Whereas the behavior of Met-Hg in humans is relatively well known, that of ethylmercury (Et-Hg) is poorly understood. The present study describes the distribution of mercury as (-methyl, -ethyl and inorganic mercury) in rat tissues (brain, heart, kidney and liver) and blood following administration of TM or Met-Hg. Animals received one dose/day of Met-Hg or TM by gavage (0.5 mg Hg/kg). Blood samples were collected after 6, 12, 24, 48, 96 and 120 h of exposure. After 5 days, the animals were killed, and their tissues were collected. Total blood mercury (THg) levels were determined by ICP-MS, and methylmercury (Met-Hg), ethylmercury (Et-Hg) and inorganic mercury (Ino-Hg) levels were determined by speciation analysis with LC-ICP-MS. Mercury remains longer in the blood of rats treated with Met-Hg compared to that of TM-exposed rats. Moreover, after 48 h of the TM treatment, most of the Hg found in blood was inorganic. Of the total mercury found in the brain after TM exposure, 63% was in the form of Ino-Hg, with 13.5% as Et-Hg and 23.7% as Met-Hg. In general, mercury in tissues and blood following TM treatment was predominantly found as Ino-Hg, but a considerable amount of Et-Hg was also found in the liver and brain. Taken together, our data demonstrated that the toxicokinetics of TM is completely different from that of Met-Hg. Thus, Met-Hg is not an appropriate reference for assessing the risk from exposure to TM-derived Hg. It also adds new data for further studies in the evaluation of TM toxicity.

Keywords

Mercury Distribution Methylmercury Ethylmercury Inorganic mercury Speciation analysis Tissues Toxicity Thimerosal 

References

  1. Ball LK, Ball R, Pratt RD (2001) An assessment of thimerosal use in childhood vaccines. Pediatrics 107:1147–1154CrossRefPubMedGoogle Scholar
  2. Baskin DS, Ngo H, Didenko A (2003) Thimerosal iduces DNA breaks, caspase-3 activation, membrane damage, and cell death in cultured human neurons and fibroblaste. Toxicol Sci 74:361–368CrossRefPubMedGoogle Scholar
  3. Berman RF, Pessah IN, Mouton PR, Mav D, Harry J (2008) Low-level neonatal thimerosal exposure: further evaluation of altered neurotoxic potential in SJL mice. Toxicol Sci 101:294–309CrossRefPubMedGoogle Scholar
  4. Burbacher T, Rodier PM, Weiss B (1990) Methylmercury developmental neurotoxicity: a comparison of effects in humans and animals. Neurotoxicol Teratol 12:191–202CrossRefPubMedGoogle Scholar
  5. Burbacher T, Shen DD, Liberato N, Grant KS, Cernichiari E, Clarkson T (2005) Comapriosn of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal. Environ Health Perspect 113:1015–1021CrossRefPubMedGoogle Scholar
  6. Clarkson TW, Magos L, Myers GJ (2003) Human exposure to mercury: the three modern dilemmas. J Trace Elem Exp Med 16:321–343CrossRefGoogle Scholar
  7. Clarkson TW, Vyas JB, Ballatori N (2007) Mechanisms of mercury disposition in the body. Am J Ind Med 50:757–764CrossRefPubMedGoogle Scholar
  8. Geier DA, Geier MR (2006) A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States. Neuroendocrinol Lett 27:401–413PubMedGoogle Scholar
  9. Grotto D, de Castro MM, Barcelos GRM, Garcia SC, Barbosa F (2009a) Low level and sub-chronic exposure to methylmercury induces hypertension in rats: nitric oxide depletion and oxidative damage as possible mechanisms. Arch Tox 83:653–662CrossRefGoogle Scholar
  10. Grotto D, Barcelos GRM, Valentini J, Antunes LMG, Angeli JPF, Garcia SC, Barbosa F (2009b) Low levels of methylmercury induce DNA damage in rats: protective effects of selenium. Arch Tox 83:249–254CrossRefGoogle Scholar
  11. Harry GJ, Harris MW, Burka LT (2004) Mercury concentrations in brain and kidney following ethylmercury, methylmercury and thimerosal administration to neonatal mice. Toxicol Lett 154:183–189CrossRefPubMedGoogle Scholar
  12. Magos L (2003) Neurotoxic character of thimerosal and the allometric extrapolation of adult clearance half-time to infants. J Appl Toxicol 23:263–269CrossRefPubMedGoogle Scholar
  13. Mori N, Yasutake A, Hirayama K (2007) Comparative study of activities in reactive oxygen species production/defense system in mitochondria of rat brain and liver, and their susceptibility to methylmercury toxicity. Arch Tox 81:769–776CrossRefGoogle Scholar
  14. Palmer CD, Lewis M, Geraghty C, Barbosa F, Parsons P (2006) Determination of lead, cadmium and mercury in blood for assessing environmental and occupational exposures: a comparison between inductively coupled plasma-mass spectrometry and atomic absorption spectrometry. Spectrochim Acta B 61:980–990CrossRefGoogle Scholar
  15. Parran DK, Barker A, Ehrich M (2005) Effects of thimerosal on NGF sgnal transduction and cell death in neuroblastoma cells. Toxicol Sci 86:132–140CrossRefPubMedGoogle Scholar
  16. Parsons P, Barbosa F (2007) Atomic spectrometry and trends in clinical laboratory medicine. Spectrochim Acta B 62:992–1003CrossRefGoogle Scholar
  17. Rodrigues JL, Souza SS, Souza VC, Barbosa F (2010) Methylmercury and inorganic mercury determination in blood by using LC-ICP-MS with a fast sample preparation procedure. Talanta 80:1158–1163CrossRefPubMedGoogle Scholar
  18. Souza SS, Rodrigues JL, Souza VCO, Barbosa F (2010) A fast sample preparation procedure for mercury speciation in hair samples by high-performance liquid chromatography coupled to ICP-MS. J Anal Atom Spectrom 25:79–83CrossRefGoogle Scholar
  19. Tan M, Parkin JE (2000) Route of decomposition of thiomersal (thimerosal). Int J Pharm 208:23–34CrossRefPubMedGoogle Scholar
  20. Trümpler S, Lohmann W, Meermann B, Buscher W, Sperling M, Karst U (2009) Interaction of thimerosal with proteins-ethylmercury adduct formation of human serum albumin and β-lactoglobulin A. Metallomics 1:87–91CrossRefGoogle Scholar
  21. U.S. EPA (U.S. Environmental Protection Agency) (2010) Integrated risk information system. Available: http://www.epa.gov/iris/subst/0073-htm [Accessed 25 January 2010]
  22. Westphal GA, Asgari S, Schulz TG, Bünger J, Müller M, Hallier E (2003) Thimerosal induces micronuclei in the cytochalasin B block micronucleus test with human lymphocytes. Arch Tox 77:50–55CrossRefGoogle Scholar
  23. WHO (2002) WHO recommendations from the strategic advisory group of experts. Weekly Epidemiol Rec 77:305–316Google Scholar
  24. Yamamoto R, Shima M (2009) Estimation of human maximum tolerable intake for methylmercury based on two recent studies in monkeys. Arch Tox 83:1043–1048CrossRefGoogle Scholar
  25. Zareba G, Cernichiari E, Hojo R, McNitt S, Weiss B, Mumtaz MM, Jones DE, Clarkson TW (2007) Thimerosal distribution and metabolism in neonatal mice: comparison with methylmercury. J Appl Toxicol 27:511–518CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Jairo L. Rodrigues
    • 1
  • Juliana M. Serpeloni
    • 1
  • Bruno L. Batista
    • 1
  • Samuel S. Souza
    • 1
  • Fernando BarbosaJr
    • 1
  1. 1.Faculdade de Ciências Farmacêuticas de Ribeirão Preto—FCFRP, Departamento de Análises Clínicas, Toxicológicas e BromatológicasUSPRibeirão PretoBrazil

Personalised recommendations